[{"id":"50c58012-9b92-4096-929a-64264a8757b1","acronym":"","url":"https://clinicaltrials.gov/study/NCT04761614","created_at":"2024-05-16T20:32:16.261Z","updated_at":"2024-07-02T16:35:03.341Z","phase":"Phase 1","brief_title":"Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer","source_id_and_acronym":"NCT04761614","lead_sponsor":"Ning Jin","biomarkers":" IFNG • IL6 • CRP • FCGRT • LIF","pipe":"","alterations":" ","tags":["IFNG • IL6 • CRP • FCGRT • LIF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Avastin (bevacizumab) • oxaliplatin • leucovorin calcium • fluorouracil topical • riluzole"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 13","initiation":"Initiation: 04/02/2021","start_date":" 04/02/2021","primary_txt":" Primary completion: 05/06/2023","primary_completion_date":" 05/06/2023","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2024-05-16"}]